Logo image of ARMP

ARMATA PHARMACEUTICALS INC (ARMP) Stock News

NYSEARCA:ARMP - NYSE Arca - US04216R1023 - Common Stock - Currency: USD

2.04  +0.08 (+4.08%)

After market: 1.9725 -0.07 (-3.31%)

ARMP Latest News, Press Relases and Analysis

News Image
20 days ago - Zacks Investment Research

ARMP Soars 72% in a Month Following Infectious Disease Study Success

Armata Pharmaceuticals stock surges 72% in a month following superior efficacy results from a phase Ib/IIa study of AP-SA02 for treating an infectious disease.

Mentions: HALO AMRN

News Image
a month ago - Zacks Investment Research

Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates

Armata Pharmaceuticals (ARMP) delivered earnings and revenue surprises of 47.37% and 64.42%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: DTIL

News Image
a month ago - Zacks Investment Research

New Strong Sell Stocks for May 8th

ARMP, COLM and EFSI have been added to the Zacks Rank #5 (Strong Sell) List on May 8, 2025.

Mentions: COLM EFSI

News Image
a month ago - Zacks Investment Research

New Strong Sell Stocks for April 28th

CCS, ARMP and CABO have been added to the Zacks Rank #5 (Strong Sell) List on April 28, 2025.

Mentions: CCS CABO

News Image
a month ago - Zacks Investment Research

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates

ADC Therapeutics (ADCT) delivered earnings and revenue surprises of 5.26% and 26.94%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: ADCT

News Image
a month ago - Zacks Investment Research

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates

Sangamo (SGMO) delivered earnings and revenue surprises of -27.27% and 29.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: SGMO

News Image
10 months ago - InvestorPlace

ARMP Stock Earnings: Armata Pharmaceuticals Beats EPS for Q2 2024

ARMP stock results show that Armata Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.

News Image
a year ago - InvestorPlace

3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge

Discover three high-growth stock picks set for unprecedented surges in the metals, marine transportation, and pharmaceutical industries.

Mentions: SILV GSL INVA

News Image
a year ago - InvestorPlace

ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024

ARMP stock results show that Armata Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

News Image
a year ago - InvestorPlace

ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023

ARMP stock results show that Armata Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

News Image
2 years ago - Seeking Alpha

Armata Pharmaceuticals gets $25M in financing and new executive chief (NYSE:ARMP)

Biotechnology company focused on pathogen‐specific bacteriophage therapeutics for antibiotic‐resistant and difficult‐to‐treat bacterial infections, Armata Pharmaceuticals (ARMP) enters...

Mentions: INVA

News Image
2 years ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday!

Mentions: ICU IFBD CWD NBY ...

News Image
2 years ago - Seeking Alpha

Armata stock surges 15% as inhaled bacterial drug shows promise in lung disorder patients

Armata Pharmaceuticals (ARMP) said its inhaled bacterial infection drug for lung disorder was well-tolerated with a treatment emergent adverse event ((TEAE)) profile similar to placebo...